Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 688

1.

A summary of the third annual HIV microbiome workshop.

Williams B, Boucher C, Bushman F, Carrington-Lawrence S, Collman RG, Dandekar S, Dang Q, Malaspina A, Paredes R, Wilson C, Nowak P, Klatt N, Lagenaur L, Landay A.

AIDS Res Hum Retroviruses. 2018 Aug 14. doi: 10.1089/AID.2018.0103. [Epub ahead of print]

PMID:
30105916
2.

Investigating Effects of Tulathromycin Metaphylaxis on the Fecal Resistome and Microbiome of Commercial Feedlot Cattle Early in the Feeding Period.

Doster E, Rovira P, Noyes NR, Burgess BA, Yang X, Weinroth MD, Lakin SM, Dean CJ, Linke L, Magnuson R, Jones KI, Boucher C, Ruiz J, Belk KE, Morley PS.

Front Microbiol. 2018 Jul 30;9:1715. doi: 10.3389/fmicb.2018.01715. eCollection 2018.

3.

Reply to Darcis and Berkhout.

Wijting IEA, Lungu C, Rijnders BJA, van der Ende ME, Pham HT, Mesplede T, Pas SD, Voermans JJC, Schuurman R, van de Vijver DAMC, Boers PHM, Gruters RA, Boucher CAB, van Kampen JJA.

J Infect Dis. 2018 Aug 2. doi: 10.1093/infdis/jiy475. [Epub ahead of print] No abstract available.

PMID:
30085047
4.
5.

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C.

Popping S, Cento V, García F, Ceccherini-Silberstein F, Seguin-Devaux C, Vijver DA, Boucher CA.

J Virus Erad. 2018 Jul 1;4(3):179-181.

6.

Cyclooxygenases and lipoxygenases are used by the fungus Podospora anserina to repel nematodes.

Ferrari R, Lacaze I, Le Faouder P, Bertrand-Michel J, Oger C, Galano JM, Durand T, Moularat S, Chan Ho Tong L, Boucher C, Kilani J, Petit Y, Vanparis O, Trannoy C, Brun S, Lalucque H, Malagnac F, Silar P.

Biochim Biophys Acta. 2018 Jul 17;1862(10):2174-2182. doi: 10.1016/j.bbagen.2018.07.012. [Epub ahead of print]

PMID:
30025856
7.

Comparative efficacy of three antiseptics as surgical skin preparations in dogs.

Boucher C, Henton MM, Becker PJ, Kirberger RM, Hartman MJ.

Vet Surg. 2018 Jul 13. doi: 10.1111/vsu.12913. [Epub ahead of print]

PMID:
30004127
8.

Practical Dynamic de Bruijn Graphs.

Crawford V, Kuhnle A, Boucher C, Chikhi R, Gagie T.

Bioinformatics. 2018 Jun 22. doi: 10.1093/bioinformatics/bty500. [Epub ahead of print]

PMID:
29939217
9.

New role of P2X7 receptor in an Alzheimer's disease mouse model.

Martin E, Amar M, Dalle C, Youssef I, Boucher C, Le Duigou C, Brückner M, Prigent A, Sazdovitch V, Halle A, Kanellopoulos JM, Fontaine B, Delatour B, Delarasse C.

Mol Psychiatry. 2018 Jun 22. doi: 10.1038/s41380-018-0108-3. [Epub ahead of print]

PMID:
29934546
10.

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

Colagrossi L, Hermans LE, Salpini R, Di Carlo D, Pas SD, Alvarez M, Ben-Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Lepej SZ, Weis N, Yalcinkaya T, Boucher CAB, Wensing AMJ, Perno CF, Svicher V; HEPVIR working group of the European Society for translational antiviral research (ESAR).

BMC Infect Dis. 2018 Jun 1;18(1):251. doi: 10.1186/s12879-018-3161-2.

11.

Error correcting optical mapping data.

Mukherjee K, Washimkar D, Muggli MD, Salmela L, Boucher C.

Gigascience. 2018 Jun 1;7(6). doi: 10.1093/gigascience/giy061.

12.

Selection of Avibacterium paragallinarum Page serovar B strains for an infectious coryza vaccine.

Sun H, Xie S, Li X, Xu F, Li Y, Boucher CE, Chen X.

Vet Immunol Immunopathol. 2018 May;199:77-80. doi: 10.1016/j.vetimm.2018.04.001. Epub 2018 Apr 5.

PMID:
29678233
13.

Counting motifs in dynamic networks.

Mukherjee K, Hasan MM, Boucher C, Kahveci T.

BMC Syst Biol. 2018 Apr 11;12(Suppl 1):6. doi: 10.1186/s12918-018-0533-6.

14.

State of the Art in HIV Drug Resistance: Science and Technology Knowledge Gap.

Boucher CA, Bobkova MR, Geretti AM, Hung CC, Kaiser R, Marcelin AG, Streinu-Cercel A, van Wyk J, Dorr P, Vandamme AM.

AIDS Rev. 2018 Jan-Mar;20(1):27-42.

PMID:
29628515
15.

State of the Art in HIV Drug Resistance: Surveillance and Regional Gaps.

Boucher CA, Bobkova MR, Hung CC, Kaiser R, Marcelin AG, Streinu-Cercel A, van Wyk J, Dorr P, Vandamme AM.

AIDS Rev. 2018 Jan-Mar;20(1):43-57.

PMID:
29628514
16.

The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors.

Pham HT, Labrie L, Wijting IEA, Hassounah S, Lok KY, Portna I, Goring ME, Han Y, Lungu C, van der Ende ME, Brenner BG, Boucher CA, Rijnders BJA, van Kampen JJA, Mesplède T, Wainberg MA.

J Infect Dis. 2018 Jul 24;218(5):698-706. doi: 10.1093/infdis/jiy175.

PMID:
29617824
17.

HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy.

Wijting IEA, Lungu C, Rijnders BJA, van der Ende ME, Pham HT, Mesplede T, Pas SD, Voermans JJC, Schuurman R, van de Vijver DAMC, Boers PHM, Gruters RA, Boucher CAB, van Kampen JJA.

J Infect Dis. 2018 Jul 24;218(5):688-697. doi: 10.1093/infdis/jiy176.

PMID:
29617822
18.

A quality improvement project to increase self-administration of medicines in an acute hospital.

Garfield S, Bell H, Nathan C, Randall S, Husson F, Boucher C, Taylor A, Lloyd J, Backhouse A, Ritchie L, Franklin BD.

Int J Qual Health Care. 2018 Jun 1;30(5):396-407. doi: 10.1093/intqhc/mzy035.

19.

A General Framework for 3-D Parameters Estimation of Roads Using GPS, OSM and DEM Data.

Boucher C, Noyer JC.

Sensors (Basel). 2017 Dec 25;18(1). pii: E41. doi: 10.3390/s18010041.

20.

Insights on transmission of HIV from phylogenetic analysis to locally optimize HIV prevention strategies.

van de Vijver DAMC, Boucher CAB.

Curr Opin HIV AIDS. 2018 Mar;13(2):95-101. doi: 10.1097/COH.0000000000000443.

PMID:
29266012
21.

Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study.

Lina B, Boucher C, Osterhaus A, Monto AS, Schutten M, Whitley RJ, Nguyen-Van-Tam JS.

Influenza Other Respir Viruses. 2018 Mar;12(2):267-278. doi: 10.1111/irv.12534. Epub 2018 Jan 15.

22.

Ending the epidemic: Critical role of primary HIV infection.

Prins HAB, Verbon A, Boucher CAB, Rokx C.

Neth J Med. 2017 Oct;75(8):321-327. Review.

23.

Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.

Boerekamps A, van den Berk GE, Lauw FN, Leyten EM, van Kasteren ME, van Eeden A, Posthouwer D, Claassen MA, Dofferhoff AS, Verhagen DWM, Bierman WF, Lettinga KD, Kroon FP, Delsing CE, Groeneveld PH, Soetekouw R, Peters EJ, Hullegie SJ, Popping S, van de Vijver DAMC, Boucher CA, Arends JE, Rijnders BJ.

Clin Infect Dis. 2018 Apr 17;66(9):1360-1365. doi: 10.1093/cid/cix1007.

PMID:
29186320
24.

19p13 microduplications encompassing NFIX are responsible for intellectual disability, short stature and small head circumference.

Trimouille A, Houcinat N, Vuillaume ML, Fergelot P, Boucher C, Toutain J, Caignec CL, Vincent M, Nizon M, Andrieux J, Vanlerberghe C, Delobel B, Duban B, Mansour S, Baple E, McKeown C, Poke G, Robertshaw K, Fifield E, Fabretto A, Pecile V, Gasparini P, Carrozzi M, Lacombe D, Arveiler B, Rooryck C, Moutton S.

Eur J Hum Genet. 2018 Jan;26(1):85-93. doi: 10.1038/s41431-017-0037-7. Epub 2017 Nov 28.

PMID:
29184170
25.

Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial.

Wijting I, Rokx C, Boucher C, van Kampen J, Pas S, de Vries-Sluijs T, Schurink C, Bax H, Derksen M, Andrinopoulou ER, van der Ende M, van Gorp E, Nouwen J, Verbon A, Bierman W, Rijnders B.

Lancet HIV. 2017 Dec;4(12):e547-e554. doi: 10.1016/S2352-3018(17)30152-2. Epub 2017 Oct 26.

PMID:
29107562
26.

Enrichment allows identification of diverse, rare elements in metagenomic resistome-virulome sequencing.

Noyes NR, Weinroth ME, Parker JK, Dean CJ, Lakin SM, Raymond RA, Rovira P, Doster E, Abdo Z, Martin JN, Jones KL, Ruiz J, Boucher CA, Belk KE, Morley PS.

Microbiome. 2017 Oct 17;5(1):142. doi: 10.1186/s40168-017-0361-8.

27.

Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.

Godfrey C, Bobkova M, Boucher C, Ravasi G, Chen P, Zhang F, Wu Y, Kantor R.

J Infect Dis. 2017 Dec 1;216(suppl_9):S816-S819. doi: 10.1093/infdis/jix408.

PMID:
28968824
28.

A Summary of the Second Annual HIV Microbiome Workshop.

Williams B, Ghosh M, Boucher CAB, Bushman F, Carrington-Lawrence S, Collman RG, Dandekar S, Dang Q, Malaspina A, Paredes R, Wilson CC, Nowak P, Klatt NR, Lagenaur L, Landay AL.

AIDS Res Hum Retroviruses. 2017 Dec;33(12):1258-1264. doi: 10.1089/aid.2017.0137. Epub 2017 Oct 26.

PMID:
28899105
29.

First female prenatal case of osteopathia striata with cranial sclerosis in a fetus carrying a de-novo 1.9 Mbp interstitial deletion at Xq11.1q11.2.

Vuillaume ML, Valard AG, Houcinat N, Bouron J, Boucher C, Deves S, Toutain J, Schaub B, Adenet C, Lacombe D, Gueneret M, Rooryck C.

Clin Dysmorphol. 2017 Oct;26(4):231-234. doi: 10.1097/MCD.0000000000000192. No abstract available.

PMID:
28799946
30.

Identification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve Patients.

Raj VS, Hundie GB, Schürch AC, Smits SL, Pas SD, Le Pogam S, Janssen HLA, de Knegt RJ, Osterhaus ADME, Najera I, Boucher CA, Haagmans BL.

Sci Rep. 2017 Jul 5;7(1):4688. doi: 10.1038/s41598-017-04931-y.

31.

Methodological concerns regarding a PrEP model - Authors' reply.

Nichols BE, Boucher CAB, van de Vijver DAM.

Lancet Infect Dis. 2017 May;17(5):482-483. doi: 10.1016/S1473-3099(17)30205-0. No abstract available.

PMID:
28447955
32.

Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.

Hankins CA, Koulla-Shiro S, Kilmarx P, Ferrari G, Schechter M, Kane CT, Venter F, Boucher CA, Ross AL, Zewdie D, Eholié SP, Katabira E.

Antivir Ther. 2017;22(2):179-184. doi: 10.3851/IMP3165. Epub 2017 Apr 7.

33.

Letter to the editor: Pre-exposure prophylaxis for HIV in Europe: The need for resistance surveillance.

van Tienen C, van de Vijver D, Noori T, Sönnerborg A, Boucher C.

Euro Surveill. 2017 Mar 16;22(11). pii: 30483. doi: 10.2807/1560-7917.ES.2017.22.11.30483. No abstract available.

34.

Targeted Enrichment for Pathogen Detection and Characterization in Three Felid Species.

Lee JS, Mackie RS, Harrison T, Shariat B, Kind T, Kehl T, Löchelt M, Boucher C, VandeWoude S.

J Clin Microbiol. 2017 Jun;55(6):1658-1670. doi: 10.1128/JCM.01463-16. Epub 2017 Mar 22.

35.

Succinct colored de Bruijn graphs.

Muggli MD, Bowe A, Noyes NR, Morley PS, Belk KE, Raymond R, Gagie T, Puglisi SJ, Boucher C.

Bioinformatics. 2017 Oct 15;33(20):3181-3187. doi: 10.1093/bioinformatics/btx067.

PMID:
28200001
36.

Lactococcus garvieae: an emerging bacterial pathogen of fish.

Meyburgh CM, Bragg RR, Boucher CE.

Dis Aquat Organ. 2017 Feb 8;123(1):67-79. doi: 10.3354/dao03083. Review.

PMID:
28177294
37.

MEGARes: an antimicrobial resistance database for high throughput sequencing.

Lakin SM, Dean C, Noyes NR, Dettenwanger A, Ross AS, Doster E, Rovira P, Abdo Z, Jones KL, Ruiz J, Belk KE, Morley PS, Boucher C.

Nucleic Acids Res. 2017 Jan 4;45(D1):D574-D580. doi: 10.1093/nar/gkw1009. Epub 2016 Nov 28.

38.

Evaluation of the ERIC-PCR as a probable method to differentiate Avibacterium paragallinarum serovars.

Hellmuth JE, Hitzeroth AC, Bragg RR, Boucher CE.

Avian Pathol. 2017 Jun;46(3):272-277. doi: 10.1080/03079457.2016.1259610. Epub 2017 Feb 8.

PMID:
27866411
39.

Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.

Martin E, Boucher C, Fontaine B, Delarasse C.

Aging Cell. 2017 Feb;16(1):27-38. doi: 10.1111/acel.12522. Epub 2016 Oct 8.

40.

Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study.

Nichols BE, Boucher CAB, van der Valk M, Rijnders BJA, van de Vijver DAMC.

Lancet Infect Dis. 2016 Dec;16(12):1423-1429. doi: 10.1016/S1473-3099(16)30311-5. Epub 2016 Sep 22.

PMID:
27665989
41.

Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.

Mélard P, Idrissi Y, Andrique L, Poglio S, Prochazkova-Carlotti M, Berhouet S, Boucher C, Laharanne E, Chevret E, Pham-Ledard A, De Souza Góes AC, Guyonnet-Duperat V, Bibeyran A, Moreau-Gaudry F, Vergier B, Beylot-Barry M, Merlio JP, Cappellen D.

Oncotarget. 2016 Oct 18;7(42):68734-68748. doi: 10.18632/oncotarget.11930.

42.

Molecular evolutionary dynamics of cytochrome P450 monooxygenases across kingdoms: Special focus on mycobacterial P450s.

Parvez M, Qhanya LB, Mthakathi NT, Kgosiemang IK, Bamal HD, Pagadala NS, Xie T, Yang H, Chen H, Theron CW, Monyaki R, Raselemane SC, Salewe V, Mongale BL, Matowane RG, Abdalla SM, Booi WI, van Wyk M, Olivier D, Boucher CE, Nelson DR, Tuszynski JA, Blackburn JM, Yu JH, Mashele SS, Chen W, Syed K.

Sci Rep. 2016 Sep 12;6:33099. doi: 10.1038/srep33099.

43.

aPPRove: An HMM-Based Method for Accurate Prediction of RNA-Pentatricopeptide Repeat Protein Binding Events.

Harrison T, Ruiz J, Sloan DB, Ben-Hur A, Boucher C.

PLoS One. 2016 Aug 25;11(8):e0160645. doi: 10.1371/journal.pone.0160645. eCollection 2016.

44.

Zika Virus: Where Is the Treatment?

Mumtaz N, van Kampen JJ, Reusken CB, Boucher CA, Koopmans MP.

Curr Treat Options Infect Dis. 2016;8:208-211. Epub 2016 Jul 8. Review. No abstract available.

45.

How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health Impact.

Dimitrov DT, Boily MC, Hallett TB, Albert J, Boucher C, Mellors JW, Pillay D, van de Vijver DA.

PLoS One. 2016 Jul 8;11(7):e0158620. doi: 10.1371/journal.pone.0158620. eCollection 2016.

46.

Unite forces to validate biomarkers in the quest for lasting HIV remission.

Rokx C, Vella S, Pantaleo G, Lévy Y, Boucher CA.

AIDS. 2016 Jul 17;30(11):1859-60. doi: 10.1097/QAD.0000000000001118. No abstract available.

PMID:
27351931
47.

Prostaglandin EP2 receptor signaling protects human trabecular meshwork cells from apoptosis induced by ER stress through down-regulation of p53.

Kalouche G, Boucher C, Coste A, Debussche L, Orsini C, Baudouin C, Debeir T, Vigé X, Rostène W.

Biochim Biophys Acta. 2016 Sep;1863(9):2322-32. doi: 10.1016/j.bbamcr.2016.06.008. Epub 2016 Jun 17.

48.

A Summary of the First HIV Microbiome Workshop 2015.

Williams B, Mirmonsef P, Boucher CA, Bushman F, Carrington-Lawrence S, Collman RG, Dandekar S, Dang Q, Malaspina A, Paredes R, Stone A, Landay A.

AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):935-941. Epub 2016 Jul 14.

PMID:
27267576
49.

The global spread of HIV-1 subtype B epidemic.

Magiorkinis G, Angelis K, Mamais I, Katzourakis A, Hatzakis A, Albert J, Lawyer G, Hamouda O, Struck D, Vercauteren J, Wensing A, Alexiev I, Åsjö B, Balotta C, Gomes P, Camacho RJ, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kostrikis LG, Lepej SJ, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stöckl E, Schmit JC, Sönnerborg A, Staneková D, Stanojevic M, Stylianou DC, Boucher CAB; SPREAD program, Nikolopoulos G, Vasylyeva T, Friedman SR, van de Vijver D, Angarano G, Chaix ML, de Luca A, Korn K, Loveday C, Soriano V, Yerly S, Zazzi M, Vandamme AM, Paraskevis D.

Infect Genet Evol. 2016 Dec;46:169-179. doi: 10.1016/j.meegid.2016.05.041. Epub 2016 Jun 2.

50.

Characterization of the resistome in manure, soil and wastewater from dairy and beef production systems.

Noyes NR, Yang X, Linke LM, Magnuson RJ, Cook SR, Zaheer R, Yang H, Woerner DR, Geornaras I, McArt JA, Gow SP, Ruiz J, Jones KL, Boucher CA, McAllister TA, Belk KE, Morley PS.

Sci Rep. 2016 Apr 20;6:24645. doi: 10.1038/srep24645.

Supplemental Content

Loading ...
Support Center